In vitro Lipolysis: An Indispensable Tool for the Development of IVIVC of Lipid Based Drug Delivery Systems

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13774

Full metadata record

DC Field	Value	Language
dc.contributor.author	Singhvi, Gautam	-
dc.date.accessioned	2024-01-10T07:12:56Z	-
dc.date.available	2024-01-10T07:12:56Z	-
dc.date.issued	2017	-
dc.identifier.uri	https://benthamscience.com/article/86060	-
dc.identifier.uri	http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13774	-
dc.description.abstract	Around 70% of the pipeline drugs and 40% of marketed drugs come under the BCS class of II and IV. Dissolution of these drugs is a major concern for formulation scientists as poorly soluble drugs consequently affects the bioavailavbility, thus reducing the therapeautic efficacy of these drugs	en_US
dc.language.iso	en	en_US
dc.publisher	Bentham Science	en_US
dc.subject	Pharmacy	en_US
dc.subject	IVIVC	en_US
dc.subject	Lipolysis	en_US
dc.subject	Lipid based drug delivery systems	en_US
dc.subject	Biopharmaceutical Classification System (BCS)	en_US
dc.subject	In vitro characterisation	en_US
dc.title	In vitro Lipolysis: An Indispensable Tool for the Development of IVIVC of Lipid Based Drug Delivery Systems	en_US
dc.type	Article	en_US
Appears in Collections:	Department of Pharmacy

Files in This Item:

There are no files associated with this item.